✦ LIBER ✦

Erlotinib and docetaxel in relapsed non-small cell lung cancer: a single centre experience

✍ Scribed by Hook, J.; MacDermott, C.; Cheeseman, S.; Conn, A.

Book ID: 118574203
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 49 KB
Volume: 63
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(09)70024-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erlotinib, docetaxel, and gefitinib in s

Erlotinib, docetaxel, and gefitinib in sequential cohorts with relapsed non-small cell lung cancer

✍ Popat, Sanjay; Barbachano, Yolanda; Ashley, Sue; Norton, Alison; O’Brien, Mary 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 237 KB

20 A single centre experience of erlotin

20 A single centre experience of erlotinib in unselected and wild type EGFR patients with non small cell lung cancer

✍ Walter, H.S.; Ahmed, S.I. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 44 KB

23 Experience of erlotinib for non-small

23 Experience of erlotinib for non-small cell lung cancer (NSCLC) at the Exeter Oncology Centre

✍ Minear, F.G.; Ward, A.J.; Dorey, N.E.; Osborne, M.E.; Toy, E.W. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 35 KB

Tarceva in relapsed non-small cell lung

Tarceva in relapsed non-small cell lung cancer: experience from Northwest England

✍ Amir, E.; Busato, S.; Köhler, J.; Lorigan, P.; Thatcher, N.; Blackhall, F. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 51 KB

PCN77 PHARMACOECONOMIC ANALYSIS OF ERLOT

PCN77 PHARMACOECONOMIC ANALYSIS OF ERLOTINIB COMPARED WITH DOCETAXEL FOR THE TREATMENT OF RELAPSED NON-SMALL-CELL LUNG CANCER (NSCLC) IN TURKEY

✍ O Batigun; E Yildirim 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

Erlotinib in Previously Treated Non–Smal

Erlotinib in Previously Treated Non–Small-Cell Lung Cancer

✍ Shepherd, Frances A.; Rodrigues Pereira, José; Ciuleanu, Tudor; Tan, Eng Huat; H 📂 Article 📅 2005 🏛 Massachusetts Medical Society 🌐 English ⚖ 269 KB